edetic acid has been researched along with Parkinson Disease in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (44.44) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, D; Wiemerslage, L | 1 |
| Arstrand, K; Dizdar, N; Kågedal, B | 1 |
| Cunningham, S; Hillard, CJ; Kalivendi, SV; Kalyanaraman, B; Kotamraju, S; Shang, T | 1 |
| Kang, JH; Kim, KS | 1 |
| d'Ischia, M; Misuraca, G; Napolitano, A; Pezzella, A; Prota, G | 1 |
| Adam, MJ; Allen, G; Burns, RS; Calne, DB; Guttman, M; Martin, WR; Parker, RA; Peppard, RF; Ruth, TJ; Tulipan, NB | 1 |
| Delesie, R; Fahn, S; Prasad, AL | 1 |
| Dugan, T; Ruhf, RC; Smyth, LT; Whitman, NE | 1 |
| Mikhaĭlov, VA | 1 |
9 other study(ies) available for edetic acid and Parkinson Disease
| Article | Year |
|---|---|
Role of Drosophila calcium channel cacophony in dopaminergic neurodegeneration and neuroprotection.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Calcium Channels; Calcium Chelating Agents; Dopaminergic Neurons; Drosophila; Drosophila Proteins; Edetic Acid; Embryo, Nonmammalian; Mutation; Nerve Degeneration; Neuroprotective Agents; Parkinson Disease; Primary Cell Culture; Quinpirole; Receptors, Dopamine D2 | 2015 |
Analysis of L-dopa in human serum.
Topics: Antiparkinson Agents; Chromatography, Affinity; Edetic Acid; Formates; Humans; Hydrogen-Ion Concentration; Levodopa; Methyldopa; Parkinson Disease; Reference Standards | 2002 |
1-Methyl-4-phenylpyridinium (MPP+)-induced apoptosis and mitochondrial oxidant generation: role of transferrin-receptor-dependent iron and hydrogen peroxide.
Topics: 1-Methyl-4-phenylpyridinium; Aconitate Hydratase; Animals; Antioxidants; Apoptosis; Caspase 3; Caspases; Cells, Cultured; Deferoxamine; Edetic Acid; Female; Glutathione Peroxidase; Glutathione Peroxidase GPX1; Humans; Hydrogen Peroxide; Iron; Iron Chelating Agents; Male; Metalloporphyrins; Mitochondria; NADH, NADPH Oxidoreductases; Neurons; Oxidants; Oxidative Stress; Parkinson Disease; Reactive Oxygen Species; Receptors, Transferrin; Staining and Labeling; Transferrin | 2003 |
Enhanced oligomerization of the alpha-synuclein mutant by the Cu,Zn-superoxide dismutase and hydrogen peroxide system.
Topics: alpha-Synuclein; Amino Acid Substitution; Anserine; Antioxidants; Antiparkinson Agents; Biopolymers; Carnosine; Chelating Agents; Codon; Copper; Edetic Acid; Free Radical Scavengers; Humans; Hydrogen Peroxide; Hydroxyl Radical; Isopropyl Thiogalactoside; Lewy Bodies; Mutagenesis, Site-Directed; Nerve Tissue Proteins; Oxidative Stress; Parkinson Disease; Phenylmethylsulfonyl Fluoride; Point Mutation; Resins, Synthetic; Spin Labels; Superoxide Dismutase; Superoxide Dismutase-1; Synucleins; Tyrosine | 2003 |
Iron-mediated generation of the neurotoxin 6-hydroxydopamine quinone by reaction of fatty acid hydroperoxides with dopamine: a possible contributory mechanism for neuronal degeneration in Parkinson's disease.
Topics: Dopamine; Edetic Acid; Humans; Hydroxydopamines; Iron; Kinetics; Linoleic Acids; Lipid Peroxides; Nerve Degeneration; Neurotoxins; Parkinson Disease; Quinones | 1997 |
PET studies of parkinsonian patients treated with autologous adrenal implants.
Topics: Adrenal Medulla; Adult; Blood-Brain Barrier; Edetic Acid; Evaluation Studies as Topic; Female; Fluorine Radioisotopes; Gallium Radioisotopes; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Tomography, Emission-Computed | 1989 |
A reliable and simple method for simultaneous determination of DOPA and 3-O-methyldopa in plasma and brain.
Topics: Antiparkinson Agents; Brain Chemistry; Carbon Isotopes; Chromatography, Ion Exchange; Cold Temperature; Dihydroxyphenylalanine; Edetic Acid; Epinephrine; Ferricyanides; Humans; Hydrazines; Hydrogen-Ion Concentration; Iodine; Methods; Methyldopa; Norepinephrine; Oxidation-Reduction; Parkinson Disease; Perchlorates; Periodic Acid; Spectrometry, Fluorescence | 1972 |
Clinical manganism and exposure to manganese in the production and processing of ferromanganese alloy.
Topics: Air Pollution; Calcium; Central Nervous System Diseases; Diagnosis, Differential; Dust; Edetic Acid; Environmental Exposure; Humans; Iron; Male; Manganese; Maximum Allowable Concentration; Middle Aged; Occupational Diseases; Parkinson Disease; Ventilation | 1973 |
[Pathogenesis and therapy of manganese poisoning (review)].
Topics: Edetic Acid; Manganese Poisoning; Monoamine Oxidase Inhibitors; Neurologic Manifestations; Occupational Diseases; Parasympatholytics; Parkinson Disease; Parkinson Disease, Secondary | 1971 |